|
EGF vaccine- Advanced Lung tumors |
2013-06-20 |
CIM |
|
Combined Subcutaneous immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
2012-04-13 |
BIOCEN |
|
Evaluation of Safety and Efficacy of T1h (anti-CD6) as Monotherapy and in Combination with Methotrexate in Patientes with Rheumatoid Arthritis |
2010-12-27 |
CIM |
|
Clinical trial, phase II, to evaluate rhEGF efficacy and safety at a dose of 25 or 75 micrograms intralesionally in patients with diabetic foot ulcer (Wagner grade 1 or 2). |
2010-12-24 |
CIGB |
|
Effect and Safety of ior® EPOCIM in patients with Non-Hodking Lymphoma treated with anthracyclines. |
2010-06-11 |
CIMAB |
|
EPOCIM in benign prostatic hyperplasia. |
2009-10-23 |
CIMAB |
|
Safety evaluation of Recombinant Human Erythropoietin ior EPOCIM in the treatment of patient with cerebral infarction acute. Study Stage I. |
2009-07-03 |
CIMAB |
|
Combifer vs NeotrofinCF-Anemia-Pregnant-Phase II |
13/04/2015 |
BIOCEN |
|
Evaluation of Biomodulin T sublingual Vs intramuscular in the elderly. |
13/04/2015 |
BIOCEN |
|
Nasalferon in COVID-19 |
12/11/2021 |
CIGB |
|
Combifer vs Trofin phase II in anemic pregnant women. |
08/04/2015 |
BIOCEN |
|
Pharmacodynamics of the Nasalferon in healthy volunteers. |
03/05/2020 |
CIGB |
|
NeuroEPO in stroke |
02/08/2018 |
CIM |
